Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Amgen Shares Rise as Earnings Estimates Come Under Pressure

Guavy AI Editorial Team
Instruments
AMGN
Share

Amgen Inc. shares rose 1.95% on September 21, 2026, closing at $393.16 on the Nasdaq after a strong trading session.

The move came as broader Nasdaq trading strengthened, with Amgen's stock gaining $7.51 during the day from its prior close of $385.65.

The increase in share price follows fresh coverage of earnings estimates and the company's late-stage pipeline, which has been under scrutiny recently.

In a report by MarketBeat on September 22, 2026, Erste Group Bank brokers reduced their earnings estimates for Amgen, citing concerns about valuation and future earnings delivery.

More on Stocks

Stocks just now

RBC Capital Markets Sticks with Outperform Rating on Sherwin-Williams

Stocks 1m ago

JPMorgan Pursues Strategic Deals Amid Strong Organic Growth

Stocks 1m ago

JPMorgan Chase Issues Notes Linked to U.S. Equities Amid Tax Warning

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy